Eli Lilly and Company lilly.com


Public list: BIO 2016 (619) Pharma Startups (6570)

Eli Lilly and Company (NYSE: LLY) is a global healthcare company that unites caring with discovery to make life better for people around the world. Lilly works to discover and bring medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

Eli Lilly and Company (NYSE: LLY) is a global healthcare company that unites caring with discovery to make life better for people around the world. Lilly works to discover and bring medicines to those who need them, improve the understanding and mana...Show all

Company (IPO / Went public)

Phone: 800-545-5979

Fax:

Lilly Corporate Center

Indianapolis, 46285
Indiana, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Eli Lilly and Company $0M Apr 28, 2021
See all 7 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Eli Lilly and Company Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Regeneron Pharmaceuticals

Tarrytown, New York, United States
IPO / Went publicRegeneron Pharmaceuticals is a science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL cholesterol and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, atopic dermatitis, asthma, pain, cancer and infectious diseases.Login to see details

Novartis

Basel, Switzerland
IPO / Went publicNovartis (NYSE: NVS) is a global healthcare company that provides solutions to address the evolving needs of patients worldwide. Focusing solely on healthcare, Novartis offers a diversified portfolio to meet these needs including medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools, and consumer health products.Login to see details
See all 7 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Dose detection for a medication delivery device Dec 11, 2020 Apr 27, 2021 Patent
Combination therapy Aug 03, 2017 Apr 27, 2021 Patent
Injection device drive with two gear patterns May 12, 2016 Apr 27, 2021 Patent
Kras g12c inhibitors Oct 08, 2019 Apr 06, 2021 Patent
Display screen with a graphical user interface Oct 31, 2019 Mar 30, 2021 Patent
See all 586 patents